Table 5.
Biomarker | n | Change GFR (95% CI) | P |
---|---|---|---|
IFN-γa | 48 | −5.1 (−8.7, −1.5) | 0.006 |
IL-1a | 48 | −4.4 (−8.1, −0.8) | 0.019 |
TNF | 48 | −6.7 (−10.0, −3.3) | <0.001 |
sTNF-R1 | 47 | −9.0 (−11.9, −6.2) | <0.001 |
FGF-23a | 48 | −8.1 (−11.2, −5.0) | <0.001 |
YKL-40 | 47 | −4.8 (−8.5, −1.1) | 0.011 |
Brain natriuretic peptidea | 46 | −0.9 (−4.8, 3.1) | 0.667 |
Shown are the cross-sectional associations of biomarkers at the baseline study visit with eGFR at the baseline study visit using linear regression. Negative values indicate that higher baseline biomarker level was associated with a lower GFR at the baseline study visit.
aSkewed variables were natural log transformed, and each biomarker was subsequently modeled as per 1 SD higher to facilitate comparison in strengths of association.